Sun Pharma Advanced Research Company Limited (NSE:SPARC)
India flag India · Delayed Price · Currency is INR
196.71
-2.88 (-1.44%)
Aug 21, 2026, 3:29 PM IST

NSE:SPARC Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-11.5519.6453.35.8412.24
Short-Term Investments
---1,5001,110-
Trading Asset Securities
---18.012,909116.65
Cash & Short-Term Investments
11.5511.5519.641,5714,025128.89
Cash Growth
-41.17%-41.17%-98.75%-60.96%3022.58%-18.06%
Accounts Receivable
-82.71160.57184.03362.31305.65
Other Receivables
-13.3323.59399.2228.250.26
Receivables
-97.74185.78585.46395.95309.25
Inventory
-25.1419.5414.7910.6610.78
Prepaid Expenses
-32.6135.9748.1933.2824.76
Other Current Assets
-18,4571.04474.1185.02237.84
Total Current Assets
-18,624261.972,6944,550711.52
Property, Plant & Equipment
-856.8992.551,0861,073951.18
Other Intangible Assets
-713.49536.53427.12254.68231.16
Long-Term Deferred Tax Assets
-22.6823.0912.62--
Other Long-Term Assets
-1,4921,541930.672,424906.97
Total Assets
-21,7093,3555,1508,3012,801

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-971.521,1391,4231,483721.87
Accrued Expenses
-242.22228.71374175.93147.37
Short-Term Debt
-5,5611,5824700.51-
Current Portion of Long-Term Debt
-----750
Current Portion of Leases
-15.1537.9934.930.0417.77
Current Income Taxes Payable
--4.4316.47--
Current Unearned Revenue
--408.9800.010.29
Other Current Liabilities
-750.77341.2332.29100.4476.99
Total Current Liabilities
-7,5413,7422,6511,7891,714
Long-Term Debt
--1,000---
Long-Term Leases
-16.669.49106.61126.224.37
Long-Term Unearned Revenue
-625.98625.981,0351,176668.45
Pension & Post-Retirement Benefits
-71.6822.42-11.3218.82
Other Long-Term Liabilities
-65.1664.52100.7470.0662.65
Total Liabilities
-8,3205,5253,8933,1742,489

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-324.53324.53324.53324.53271.89
Additional Paid-In Capital
-20,38220,38220,38220,38211,064
Retained Earnings
--7,324-22,876-19,449-15,578-13,366
Comprehensive Income & Other
-5.660.680.07-2,343
Shareholders' Equity
13,38813,388-2,1691,2585,128312.26
Total Liabilities & Equity
-21,7093,3555,1508,3012,801

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
5,5935,5932,689611.51156.75792.14
Net Cash (Debt)
-5,582-5,582-2,670959.83,868-663.25
Net Cash Growth
----75.19%--
Net Cash Per Share
-17.19-17.20-8.232.9613.59-2.52
Filing Date Shares Outstanding
324.69324.52324.52324.52324.52271.88
Total Common Shares Outstanding
324.69324.52324.52324.52324.52271.88
Working Capital
-11,083-3,48043.282,760-1,003
Book Value Per Share
41.2641.26-6.693.8815.801.15
Tangible Book Value
12,67512,675-2,706830.444,87381.1
Tangible Book Value Per Share
39.0639.06-8.342.5615.020.30
Land
-80.3580.3580.3580.3580.35
Buildings
-310.4310.4308.55303.62300.07
Machinery
-966.441,000993.88887.9854.83
Construction In Progress
-4.975.6112.6918.7337.2